OPTIJECT Side Effects

7007088-2 | Angioedema, Type Iv Hypersensitivity Reaction
on Sep 15, 2010 Female patient from FRANCE , 43 years of age, was diagnosed with computerised tomogram, epilepsy (What is epilepsy?) and was treated with Optiject (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, type iv hypersensitivity reaction. Optiject dosage: 100 Ml, Single. During the same period patient was treated with GARDENAL /00023201/ (View Gardenal /00023201/ Review and Gardenal /00023201/ Label ). Patient was hospitalized.

6855765-6 | Angioedema
Patient was taking Optiject (View Usage). Patient had the following side effects: angioedema on Jul 08, 2010 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with computerised tomogram and. Optiject dosage: 100 Ml, Single. Patient was hospitalized.

6819008-1 | Type I Hypersensitivity
Adverse event was reported on Jun 28, 2010 by a Male patient taking Optiject (View Usage) (Dosage: 110 Ml, Single) was diagnosed with computerised tomogram and. Location: FRANCE , weighting 176.4 lb, After Optiject was administered, patient had the following side effects: type i hypersensitivity. Patient was hospitalized.

6819004-4 | Rash Papular, Throat Tightness, Urticaria
on Jun 28, 2010 Female patient from FRANCE , 38 years of age, was diagnosed with computerised tomogram and was treated with Optiject (View Usage). Patient experienced the following unwanted or unexpected effects: rash papular, throat tightness, urticaria. Optiject dosage: Unk, Single. During the same period patient was treated with AERIUS /01398501/ (Unk) (View Aerius /01398501/ Review and Aerius /01398501/ Label ). Patient was hospitalized.


6721305-5 | Eosinophilia, Oedema Peripheral, Rash Maculo-papular
on May 05, 2010 Male patient from FRANCE , 51 years of age, was diagnosed with computerised tomogram and was treated with Optiject (View Usage). Patient had the following side effects: eosinophilia, oedema peripheral, rash maculo-papular. Optiject dosage: 125 Ml, Single. Patient was hospitalized.

6680711-8 | Dyspnoea, Rash, Tachycardia
Patient was taking Optiject (View Usage). After Optiject was administered, patient had the following side effects: dyspnoea, rash (What is rash?), tachycardia on Apr 08, 2010 from FRANCE Additional patient health information: Female patient , weighting 136.7 lb, was diagnosed with computerised tomogram and. Optiject dosage: 100 Ml, Single. Patient was hospitalized.

6648283-1 | Shock
Adverse event was reported on Mar 16, 2010 by a Female patient taking Optiject (View Usage) (Dosage: Unk, Single) was diagnosed with computerised tomogram and. Location: FRANCE , 58 years of age, Patient experienced the following unwanted or unexpected effects: shock. Patient was hospitalized.

6630751-X | Anaphylactoid Reaction, Dyspnoea, Rash, Tachycardia
on Mar 02, 2010 Female patient from FRANCE , weighting 136.7 lb, was diagnosed with computerised tomogram and was treated with Optiject (View Usage). Patient had the following side effects: anaphylactoid reaction, dyspnoea, rash (What is rash?), tachycardia. Optiject dosage: 100 Ml, Single. Patient was hospitalized.

6500025-6 | Acidosis, Anaphylactic Shock, Duodenitis, Ischaemic Hepatitis, Loss Of Consciousness
on Nov 23, 2009 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with computerised tomogram and was treated with Optiject (View Usage). After Optiject was administered, patient had the following side effects: acidosis, anaphylactic shock, duodenitis, ischaemic hepatitis, loss of consciousness. Optiject dosage: 130 Ml, Single. Patient was hospitalized.

6487297-1 | Acute Pulmonary Oedema, Cyanosis, Dyspnoea, Livedo Reticularis, Tachypnoea
Patient was taking Optiject (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, cyanosis, dyspnoea, livedo reticularis, tachypnoea on Nov 26, 2009 from FRANCE Additional patient health information: Male patient , weighting 134.5 lb, was diagnosed with computerised tomogram and. Optiject dosage: 125 Ml, Single. During the same period patient was treated with PLAVIX (Unk Df, Qd) (View Plavix Review and Plavix Label ), SELOKEN /00376902/ (100 Mg, Bid) (View Seloken /00376902/ Review and Seloken /00376902/ Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), ODRIK (4 Mg, Qd) (View Odrik Review and Odrik Label ), CRESTOR (10 Mg, Qd) (View Crestor Review and Crestor Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), PROZAC /00724401/ (30 Mg, Qd) (View Prozac /00724401/ Review and Prozac /00724401/ Label ), LEXOMIL (1 Df, Qd) (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6309878-8 | Blood Creatinine Increased, Coma, Hypotension, Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Aug 06, 2009 by a Female patient taking Optiject (View Usage) (Dosage: Unk) was diagnosed with computerised tomogram abdomen and. Location: FRANCE , 73 years of age, Patient had the following side effects: blood creatinine increased, coma, hypotension, lactic acidosis, renal failure acute. During the same period patient was treated with METFORMIN HCL (1000 Mg, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), TRIATEC /00885601/ (10 Mg, Unk) (View Triatec /00885601/ Review and Triatec /00885601/ Label ), COUMADIN (2 Mg, Unk) (View Coumadin Review and Coumadin Label ), NOVONORM (2 Mg, Unk) (View Novonorm Review and Novonorm Label ), DIAMICRON (30 Mg, Unk) (View Diamicron Review and Diamicron Label ), ELISOR (40 Mg, Unk) (View Elisor Review and Elisor Label ), CARDENSIEL (2.5 Mg, Unk) (View Cardensiel Review and Cardensiel Label ), MOPRAL /00661201/ (20 Mg, Unk) (View Mopral /00661201/ Review and Mopral /00661201/ Label ).